Author: Healio ophthalmology

ACP advocates for gender equity for physicians

Jack Ende Susan Thompson Hingle
NEW ORLEANS — ACP recently published a position paper in Annals of Internal Medicine offering recommendations on how to promote and achieve gender equity in compensation and career advancement within the medical profession.
In a press briefing at the ACP Internal Medicine Meeting, ACP leaders, including Jack Ende, MD, president of ACP, Susan Thompson Hingle, MD, chair of ACP’s Board of Regents, Darilyn Moyer, MD, executive VP and CEO of ACP, and Sue S. Bornstein, MD, chair of ACP’s Health and Public Policy Committee, discussed (Read more...)

ReSTOR 2.5 combined with ReSTOR 3.0 reduces glare and halos, need for computer glasses

John A. Hovanesian
WASHINGTON — Patients who underwent cataract surgery and received a ReSTOR 2.5 D multifocal IOL in their dominant eye and a ReSTOR 3.0 D IOL in the fellow eye reported less of a need for computer glasses and less halo and glare compared with patients who received a ReSTOR 3.0 D IOL in both eyes, according to a speaker here.
A questionnaire was administered to patients who had undergone cataract surgery with bilateral ReSTOR IOLs (Alcon). The study included 89 patients who received 2.5 D and 3.0 (Read more...)

Allergan will not bid for Shire

Allergan announced it will not make an offer for Shire.
The company will continue to evaluate its potential strategic actions, according to a press release.
Allergan will not bid for Shire plc, the company announced. Source: Shutterstock
In an earlier release, Allergan responded to media speculation regarding a possible offer by saying it would announce its intentions before the May 17 deadline under the U.K. Takeover Code.
Takeda, a Japanese-based pharmaceutical firm, offered to acquire Shire for 46.50 pounds per share. However, Shire’s board rejected the proposal.

Doctors, patients benefit when the ‘eyes’ have it

NEW ORLEANS — Maintaining as much eye contact with patients as possible improves doctors’ relationships with their patients, reduces the time spent on EHRs outside patient settings and improves one’s ‘computer-side manner,’ according to a presenter at the American College of Physicians Internal Medicine Meeting.
“Eye contact is a very big predictor of a good patient-doctor relationship. The computer can be seen as a distraction, a new sort of third-party in the room,” Wei Wei Lee MD, assistant professor of medicine at the University of Chicago told

Hydrus reduces IOP in comparison trial

David F. Chang
WASHINGTON — Data from the COMPARE trial for the Hydrus microstent vs. two iStents as a stand-alone treatment for open-angle glaucoma showed some advantages for the Hydrus, according to a speaker here.
“In the comparison, Hydrus was statistically superior in lowering the medication count, the number of eyes that were completely medication free at a year, the number of eyes in terms of preventing them from requiring three or more medications, and then in addition reducing the IOP by an additional 20%,” David F. Chang, MD, said (Read more...)

ACP calls for revision of physician performance measurements

Jack Ende

In Medicare’s Merit-based Incentive Payment System, or MIPS, most ambulatory internal medicine quality measures are not compliant with ACP criteria, according to ACP in a paper published in the New England Journal of Medicine.

“ACP has long supported and advocated improving performance measures so they help physicians provide the best possible care to their patients without creating unintended adverse consequences,” Jack Ende, MD, president of ACP, said in a press release.

To address physicians’ concerns that current performance measures do not meaningfully

Toric extended depth of focus IOL improves binocular uncorrected near visual acuity

Eric D. Donnenfeld
WASHINGTON — A nanovision strategy using extended depth of focus toric IOLs improved binocular near visual acuity in patients undergoing routine bilateral cataract surgery more than a plano strategy, according to a study presented here.
“Binocular near vision was better in the nanovision group. Nanovision, or –0.5 D of monovision in the nondominant eye, appears to improve near vision without decreasing vision at distance or intermediate in binocular vision studies,” Eric D. Donnenfeld, MD, said at the American Society of Cataract and Refractive Surgery

FDA releases action plan for medical device safety, innovation

FDA Commissioner Scott Gottlieb, MD, announced the launch of the Medical Device Safety Action Plan, which outlines how the FDA can continue to enhance programs and processes to assure the safety of medical devices.
“Our aim is to make sure that the new advances in technology that are enabling better capabilities and benefits are also harnessed to bring added assurances of safety, so that more patients can benefit from new devices and address unmet needs,” Gottlieb said in a statement.
The five areas of focus of the plan include efforts (Read more...)

Long-term data positive for IOP-lowering efficacy of iStent

John Berdal
WASHINGTON — Patients with mild to severe open-angle glaucoma who underwent cataract surgery and received an iStent experienced a 33% reduction in medication use and a clinically significant reduction in IOP at 5 years postop, according to a speaker here.
“The IOP reduction and, to a little lesser degree, the medication reduction is sustained at 5 years postoperatively. A higher preoperative IOP is associated with a higher reduction of IOP,” John P. Berdahl, MD, said at the American Society of Cataract and Refractive Surgery annual meeting.
The retrospective (Read more...)

Multiburst mode on Stellaris phaco system advantageous for early postoperative outcomes

WASHINGTON — Patients who have undergone femtosecond laser-assisted nuclear fragmentation and capsulotomy with a phaco system on multiburst mode experienced positive early postoperative outcomes, according to a speaker here.
“Multiburst modality on a Stellaris vision enhancement phaco system (Bausch + Lomb) has shown a clear overall advantage when used in combination with femto pre-softening at the different grades of cataract staging based on the LOCS III scale,” Mitchell A. Jackson, MD, said at the American Society of Cataract and Refractive Surgery annual meeting.

Neonatal caffeine therapy may improve visuomotor, visual perception outcomes

Neonatal caffeine therapy for apnea of prematurity in very low birth weight infants showed improved visuomotor, visuoperceptual and visuospatial outcomes at age 11 years compared with infants who did not receive the therapy, according to study results published in Pediatrics.
“Apnea of prematurity occurs in over 50% of preterm neonates and is most commonly created with respiratory stimulants such as caffeine,” Ines M. Mürner-Lavanchy, PhD, of Monas Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton, Australia, and Murdoch Children’s Research

Omidria maintains pupil size during femtosecond cataract surgery

WASHINGTON — Phenylephrine and ketorolac intraocular solution either maintained or increased pupil dilation through femtosecond laser-assisted cataract surgery, according to a speaker here.
While femtosecond laser-assisted surgery has many advantages, it is also associated with the formation of prostaglandins, which leads to intraoperative pupil miosis, Johnny L. Gayton, MD, said in a paper presentation at the American Society of Cataract and Refractive Surgery meeting.
“Pre-emptive use of a product to decrease prostaglandin formation and maintain intraoperative mydriasis would be

Steve Charles delivers 2018 Charles D. Kelman Innovator’s Lecture at ASCRS

Steve Charles
WASHINGTON — Steve Charles, MD, delivered the 2018 Charles D. Kelman Innovator’s Lecture at the American Society of Cataract and Refractive Surgery annual meeting and stressed the importance of collaboration, technological advances and the evolutionary nature of the development process.
Charles has transformed the field, having invented a significant number of the associated techniques and devices used by vitreoretinal surgeons worldwide. He has conducted more than 38,000 procedures, lectured in 50 countries and operated in 25 countries, said Ann Kelman, wife of the